لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Grover P; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Awosika J; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Gulati S; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Hsu CY; Vanderbilt University Medical Center, Nashville, Tennessee., Alimohamed SI; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina., Bashir B; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Berg S; Loyola University Medical Center, Maywood, Illinois., Bilen MA; Winship Cancer Institute, Emory University, Atlanta, Georgia., Bowles D; University of Colorado, Denver., Castellano C; Winship Cancer Institute, Emory University, Atlanta, Georgia., Desai A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Elkrief A; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Eton OE; Hartford Healthcare Cancer Institute, Hartford, Connecticut., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor., Flora D; St. Elizabeth Health Care, Edgewood, Kentucky., Galsky MD; Tisch Cancer Institute, Mount Sinai, New York., Gatti-Mays ME; Division of Medical Oncology, The Ohio State University, Columbus., Gesenhues A; St. Elizabeth Health Care, Edgewood, Kentucky., Glover MJ; Stanford University, Stanford, California., Gopalakrishnan D; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Gupta S; Cleveland Clinic, Cleveland, Ohio., Halfdanarson TR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Hayes-Lattin B; Knight Cancer Institute, Oregon Health and Science University, Portland., Hendawi M; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin., Hsu E; Hartford Healthcare Cancer Institute, Hartford, Connecticut., Hwang C; Henry Ford Cancer Institute, Detroit, Michigan., Jandarov R; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio., Jani C; Mt. Auburn Hospital, Boston, Massachusetts., Johnson DB; Vanderbilt University Medical Center, Nashville, Tennessee., Joshi M; Penn State Cancer Institute, Hershey, Pennsylvania., Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Khan SA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York., Knox N; Loyola University Medical Center, Maywood, Illinois., Koshkin VS; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco., Kulkarni AA; Masonic Cancer Center, University of Minnesota, Minneapolis., Kwon DH; UCSF, Helen Diller Comprehensive Cancer Center, San Francisco., Matar S; Hollings Cancer Center, MUSC, Charleston., McKay RR; Moores Cancer Center, UCSD, San Diego, California., Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee., Moria FA; McGill University Health Centre, Montreal, Quebec, Canada., Nizam A; Cleveland Clinic, Cleveland, Ohio., Nock NL; Case Comprehensive Cancer Center, Department of Population and Quantitative Health Sciences, Cleveland, Ohio., Nonato TK; Moores Cancer Center, UCSD, San Diego, California., Panasci J; Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Pomerantz L; Penn State Cancer Institute, Hershey, Pennsylvania., Portuguese AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington., Provenzano D; George Washington University, Washington, DC., Puc M; Virtua Health, Marlton, New Jersey., Rao YJ; George Washington University, Washington, DC., Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah., Riely GJ; Memorial Sloan Kettering Cancer Center, New York., Ripp JJ; University of Kansas Medical Center, Kansas City., Rivera AV; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Ruiz-Garcia E; Instituto Nacional de Cancerologia, Mexico., Schmidt AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schoenfeld AJ; Memorial Sloan Kettering Cancer Center, New York., Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York., Shah SA; Stanford University, Stanford, California., Shaya J; Moores Cancer Center, UCSD, San Diego, California., Subbiah S; Stanley S. Scott Cancer Center, LSU, New Orleans, Louisiana., Tachiki LM; Fred Hutchinson Cancer Research Center, Seattle, Washington., Tucker MD; Vanderbilt University Medical Center, Nashville, Tennessee., Valdez-Reyes M; Instituto Nacional de Cancerologia, Mexico., Weissmann LB; Mt. Auburn Hospital, Boston, Massachusetts., Wotman MT; Tisch Cancer Institute, Mount Sinai, New York., Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City., Xie Z; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Yang YJ; Vanderbilt University Medical Center, Nashville, Tennessee., Thompson MA; Aurora Cancer Center, Advocate Aurora Health, Milwaukee, Wisconsin.; Tempus Labs, Chicago, Illinois., Shah DP; Mays Cancer Center, UT Health, San Antonio, Texas., Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee., Shyr Y; Vanderbilt University Medical Center, Nashville, Tennessee., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wise-Draper TM; Division of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, Ohio.

مؤلفون مشاركون: COVID-19 and Cancer Consortium

المصدر: JAMA oncology [JAMA Oncol] 2023 Jan 01; Vol. 9 (1), pp. 128-134.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , Neoplasms*/epidemiology , Neoplasms*/therapy, Humans ; Female ; Middle Aged ; Aged ; Male ; SARS-CoV-2 ; Cohort Studies ; Retrospective Studies ; COVID-19 Testing ; Cytokine Release Syndrome/etiology ; Immunosuppression Therapy ; Immunotherapy/adverse effects

المؤلفون: Hawley JE; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York.; now with Division of Oncology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle., Sun T; Vanderbilt University Medical Center, Nashville, Tennessee., Chism DD; Thompson Cancer Survival Center, Knoxville, Tennessee., Duma N; University of Wisconsin Carbone Cancer Center, Madison., Fu JC; Tufts Medical Center Cancer Center, Boston and Stoneham, Massachusetts., Gatson NTN; Geisinger Health System, Danville, Pennsylvania.; Banner MD Anderson Cancer Center, Gilbert, Arizona., Mishra S; Vanderbilt University Medical Center, Nashville, Tennessee., Nguyen RH; University of Illinois Hospital & Health Sciences System, Chicago., Reid SA; Vanderbilt University Medical Center, Nashville, Tennessee., Serrano OK; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Singh SRK; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan., Venepalli NK; University of North Carolina, Lineberger Cancer Center, Chapel Hill., Bakouny Z; Dana-Farber Cancer Institute, Boston, Massachusetts., Bashir B; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, Georgia., Caimi PF; Case Comprehensive Cancer Center at Case Western Reserve University/University Hospitals, Cleveland, Ohio., Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts., Dawsey SJ; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Fecher LA; University of Michigan Rogel Cancer Center, Ann Arbor., Flora DB; St Elizabeth Healthcare, Edgewood, Kentucky., Friese CR; University of Michigan Rogel Cancer Center, Ann Arbor., Glover MJ; Stanford Cancer Institute at Stanford University, Palo Alto, California., Gonzalez CJ; University of Michigan Rogel Cancer Center, Ann Arbor., Goyal S; George Washington University, Washington, DC., Halfdanarson TR; Mayo Clinic, Rochester, Minnesota., Hershman DL; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Khan H; Brown University and Lifespan Cancer Institute, Providence, Rhode Island., Labaki C; Dana-Farber Cancer Institute, Boston, Massachusetts., Lewis MA; Intermountain Healthcare, Salt Lake City, Utah., McKay RR; University of California, San Diego., Messing I; George Washington University, Washington, DC., Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Puc M; Virtua Health, Marlton, New Jersey., Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, Georgia., Rhodes TD; Intermountain Healthcare, Salt Lake City, Utah., Rivera AV; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania., Roller J; University of Kansas Medical Center, Kansas City., Schwartz GK; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York., Shah SA; Stanford Cancer Institute at Stanford University, Palo Alto, California., Shaya JA; University of California, San Diego., Streckfuss M; Advocate Aurora Health, Milwaukee, Wisconsin., Thompson MA; Advocate Aurora Health, Milwaukee, Wisconsin., Wulff-Burchfield EM; University of Kansas Medical Center, Kansas City., Xie Z; Mayo Clinic, Rochester, Minnesota., Yu PP; Hartford HealthCare Cancer Institute, Hartford, Connecticut., Warner JL; Vanderbilt University Medical Center, Nashville, Tennessee., Shah DP; Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas., French B; Vanderbilt University Medical Center, Nashville, Tennessee., Hwang C; Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan.

مؤلفون مشاركون: COVID-19 and Cancer Consortium (CCC19)

المصدر: JAMA network open [JAMA Netw Open] 2022 Jan 04; Vol. 5 (1), pp. e2142046. Date of Electronic Publication: 2022 Jan 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Pandemics* , Rural Population* , Social Vulnerability* , Urban Population*, COVID-19/*epidemiology , Neoplasms/*epidemiology, Aged ; Cause of Death ; Censuses ; Female ; Health Facilities ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Odds Ratio ; Registries ; Respiration, Artificial ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Severity of Illness Index ; Spatial Analysis ; United States/epidemiology